The Official Newsroom of PT. Satoria Aneka Industri
Featured Story
With the official opening of Line 4 in Pasuruan, Satoria Pharma becomes Indonesia's largest infusion manufacturer — raising annual capacity to 230 million bottles and strengthening national pharmaceutical independence.
Line 4 at Wonorejo, Pasuruan — the largest infusion manufacturing plant in Indonesia.
Satoria Pharma completes its first international export, carrying Indonesian-made IV solutions to Southeast Asian markets and marking the start of a regional growth story.
Construction of Line 5 will lift production capacity to 400 million bottles per year by 2028, supporting export ambitions across Vietnam, Cambodia and the Philippines.
Satoria Pharma marks the start of development for two new distribution centers in Makassar and North Sulawesi — extending reliable, traceable delivery deeper into Eastern Indonesia's hospital network.
In-house Injection Stretch Blow Moulding forms pharmaceutical-grade polypropylene bottles in-line — superior container integrity at a production cost 40–50% below conventional technology, sharpening competitiveness in global markets.
Supplying approximately half of Indonesia's infusion demand at prices the national healthcare system can afford — while lightweight polypropylene bottles and efficient production reduce the material footprint of every dose.
Satoria Pharma is awarded a national tender by LKPP to distribute IV solutions to healthcare providers across Indonesia — public trust that the company has supplied continuously ever since.
Satoria Group founds its pharmaceutical manufacturing arm in Pasuruan, beside one of Indonesia's finest natural water sources — the beginning of a plant built to set a new benchmark in infusion therapy.
For press enquiries, contact info@satoriapharma.com